MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Study of Melphalan HCl for Injection (Propylene Glycol-free), Carmustine, Etoposide, Cytarabine (BEAM Regimen) and Autologous Stem Cell Transplantation for Lymphoma

Phase 2
Completed
Conditions
Hodgkin Disease
Lymphoma, Non-Hodgkin
Interventions
First Posted Date
2013-10-25
Last Posted Date
2018-02-13
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
50
Registration Number
NCT01969435
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy With Immediate Reconstruction

Not Applicable
Completed
Conditions
Ductal Carcinoma in Situ - Category
Breast Cancer
Prophylactic Mastectomy
Interventions
Procedure: Inframammary Fold Incision
Procedure: Lateral Radial Incision
Procedure: Inframammary Fold Incision or Lateral Radial Incision
Device: Laser-assisted fluorescence angiography
First Posted Date
2013-10-25
Last Posted Date
2018-04-18
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
79
Registration Number
NCT01969448
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Use of Teach Back to Improve Comprehension of Discharge Instructions for Emergency Patients With Limited Health Literacy

Not Applicable
Completed
Conditions
Conditions Influencing Health Status
Interventions
Behavioral: Teach-back
First Posted Date
2013-10-24
Last Posted Date
2013-10-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
254
Registration Number
NCT01968291
Locations
🇺🇸

Barnes-Jewish Hospital Emergency Department, St. Louis, Missouri, United States

Can Intermittent Fasting Mimic the Metabolic and Cardiovascular and Anti-aging Effects of Calorie Restriction?

Not Applicable
Completed
Conditions
Obesity
Overweight
Interventions
Other: Intermittent Fasting group
Other: control group
First Posted Date
2013-10-17
Last Posted Date
2021-05-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
50
Registration Number
NCT01964118
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation

Not Applicable
Completed
Conditions
Cancer
Interventions
Behavioral: Decision Aid (DA)
First Posted Date
2013-10-17
Last Posted Date
2015-12-07
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
201
Registration Number
NCT01964222
Locations
🇺🇸

Siteman Cancer Center, St. Louis, Missouri, United States

3D Breast Imaging for Cosmetic and Reconstructive Breast Surgery

Not Applicable
Completed
Conditions
Hypomastia
Primary Breast Augmentation
Interventions
Device: 3D Imaging
First Posted Date
2013-10-17
Last Posted Date
2017-12-26
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
100
Registration Number
NCT01964105
Locations
🇺🇸

West County Plastic Surgeons of Washington University, Saint Louis, Missouri, United States

Bilateral vs Unilateral CTR

Conditions
Carpal Tunnel Syndrome
First Posted Date
2013-10-11
Last Posted Date
2013-10-11
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
120
Registration Number
NCT01961011
Locations
🇺🇸

Washington University School of Medicine, St. Louis, Missouri, United States

Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

Phase 2
Withdrawn
Conditions
Breast Neoplasms
Interventions
First Posted Date
2013-10-01
Last Posted Date
2014-12-08
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT01953445

Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal Vagotomy

Phase 1
Withdrawn
Conditions
Does the Vagus Nerve Mediate the Effects of Xenin-25
Interventions
Drug: Graded Glucose Infusion with Placebo
Drug: Graded Glucose Infusion with GIP Alone
Drug: Graded Glucose Infusion with xenin-25 alone
Drug: Graded Glucose Infusion with GIP plus xenin-25
Drug: Meal Tolerance Test with Placebo
Drug: Meal Tolerance Test with xenin-25
First Posted Date
2013-09-27
Last Posted Date
2018-04-26
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT01951716
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Phase 1
Completed
Conditions
Pre-diabetes
Interventions
Drug: Control
Drug: GIP plus Xenin-25 without atropine
Drug: GIP plus Xenin-25 with atropine
First Posted Date
2013-09-27
Last Posted Date
2018-05-25
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
15
Registration Number
NCT01951729
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath